Treatment Of Rheumatoid ArthritisThe fact that there are many anti-inflammatory
drugs for RA should not blind patients into the belief that RA could be cured.
The very opposite is true! Evidence shows that none of the treatment modalities
is curative, but the best the patient can hope for is that the disease process
gets more controlled and that the affected joints remain functional. In the following
I will briefly summarize the available treatments in a table (gleaned from Ref.
1 and 2) and then comment on each item mentioned in more detail.
| Various treatment modalities
for rheumatoid arthritis | | Treatment
type: | Comments: |
| Initial
treatment: | side effects of
initial treatment: | | Nonsteroidal
antiinflammatories (NSAIDs) | stomach irritation,
kidney damage | | COX-2
inhibitors | more specific than NSAIDs
| | corticosteroids
| dramatic response, but only safe to
use short-term | | Slow
acting drugs for second stage: | added
after 2-4 months if NSAIDs or COX-2 inhibitors are ineffective |
| gold | injectable
gold may cause remission | | sulfasalazine | benefits
may take 6 weeks to show | | hydroxychloroquine | retinal
degeneration limits its use | | penicillamine | affects
bone marrow, kidneys, can produce a lupus like syndrome etc. |
| Immunosuppressive
drugs for resistant cases of RA: | used
for severe, active RA; they have significant toxic side-effects on liver, bone
marrow and immune cells | | methotrexate | affects
bone marrow, lungs, liver | | cyclosporine | causes
hypertension and kidney damage, hair growth, gingival hypertrophy |
| azathioprine | used
for synovitis, can cause lymphoma | | cyclophosphamide | has
same side effects as all other immunosuppressive drugs, used for vasculitis by
rheumatologist | | Newer
approaches to treatment of rheumatoid arthritis |
Treatment of the initial
phase of RA: COX-2
inhibitors, if the patient can afford it, are likely the drugs of
choice as they are not as toxic for the stomach lining or the kidney blood vessels
than the regular NSAIDs. With the VIOXX withdrawal from
the market there is now a shift in treatment back to the regular anti-inflammatories
(NSAIDS). However, because RA is an autoimmune disease, this
type of treatment only suppresses an acute flare-up. We know that untreated RA
by itself will settle down in the first year in about 75% of the cases (Ref. 2).
General supportive measures such as seeking the advice of a physiotherapist and
occupational therapist to get splints made and to preserve as much range of motion
as possible through passive exercises followed by active exercises, may be the
most important thing to do for the patient. The patient should also use aids and
appliances to make the surroundings as comfortable and safe as possible.
Corticosteroids
orally or by joint injection, if COX-2 inhibitors alone are not
helping, might very quickly settle the arthritis down with a short course of therapy
not eceeding 2 weeks. However, if corticosteroids are used for more than 2 weeks,
there is an increased risk for osteonecrosis of the hip bone, which would lead
to fractures and the need for emergency hip replacements. Other problems of longterm
corticosteroid therapy are that the immune system gets paralyzed and serious infections
including systemic fungal infections can threaten the life of patients.
Slow
acting drugs for second stage: If after 2 to 4 months there
is still no relief from the joint pains and swelling, the patient should seek
the advice of a rheumatologist or arthritis center. A decision needs to be made
whether to add one of the slow acting drugs to control the inflammation of RA.
Popular choices are either gold therapy or sulfosalazine. Each has its advantage
and disadvantage.
Gold
therapy, for instance, can sometimes show impressive results with
initial injections of gold (sodium aurothiomalate). However, longterm treatment
with gold is not tolerated as well and toxic effects of gold therapy are becoming
more evident as time goes on and gold accumulates in the system. Patients with
liver or kidney disease are not allowed to get gold therapy as gold itself affects
liver (hepatitis) and kidneys (nephrotic syndrome) negatively. Bone marrow suppression
is another danger.
Sulfasalazine,
which has been used for a long time for ulcerative colitis is often used now for
RA. It may take up to 3 months before the full effect of this agent is visible
in terms of improvement of joint swelling and pain. Side effects are gastric irritation,
bone marrow suppression, anemia due to hemolysis and a skin rash. The rheumatologist
will want to monitor the blood values closely while on this therapy. About 60%
of patients put on this medication can still tolerate it after 3 years, but about
15% will have to stop it because of toxic side effects (Ref.1).
Hydroxychloroquine
is an old anti-malarial drug that has been found in the past to be beneficial
for RA patients. It is perhaps better tolerated, but it has one serious side effect,
which limits its use: retinal damage due to an irreparable retinal degeneration.
The rheumatologist likely will want to have an ophthalmologist examine the patient
every 6 months while this medication is used. When the RA has stabilized, the
minimum possible maintenance dosage is used to minimize risk (Ref.2).
Penicillamine
is sometimes used by the rheumatologist when gold therapy fails. However,
side effects are more common than with gold therapy and include toxicity to the
bone marrow, kidneys (nephrosis), nervous system (myasthenia gravis), skin (pemphigus),
muscles (polymyositis) and a lupus like syndrome. If this medication is used,
then the specialist will have to carefully monitor for these side effects with
ongoing blood tests (Ref. 1 and 2). A metallic taste and nausea are common, but
often disappear with continued use.
Use
of immunosuppressive drugs for resistant RA cases: If the
other measures were unable to provide relief to the RA sufferer, the we are dealing
with a particularly severe case of RA. The RF titer likely is very high and the
C-reative protein as well. This means that the autoimmune bodies and the resulting
immune complexes that are formed throughout the body continue to irritate the
synovial membranes leading to more and more synovitis as well as joint and ligament
destruction. In these cases it would theoretically make sense to dampen the immune
system to control the RA. However, we are only at the beginning to learn how to
this therapy without harming the rest of the body.
Methotrexate
is one of the more popular medications. It is an anti-cancer agent and like all
these chemotherapeutic agents has a bone marrow suppressant side effect. It cannot
be used in patients who have a history of heavy alcohol consumption or in diabetics.
Liver function must be monitored. Immune supression leads to sometimes serious
viral or bacterial infections that can be life threatening. However, with low
dose intermittent methotrexate therapy some patients can be well controlled with
their RA (Ref.2).
Cyclosporine
is the medication that is used to suppress the rejection of a trasplanted
organ. The reason it can be useful for RA patients is that the autoimmune antibody
production that leads to RF can be supressed with this medication. However, it
is costly, and it has a toxic kidney effect that leads to high blood pressure.
On the other hand it does not have the bone marrow toxicity that other agents
have (Ref. 1). Other side effects are a tremor, excessive gum growth (gingival
hypertrophy), increased hair growth and interaction with a large number of drugs.
Azathioprine
seems to be useful when synovitis (swelling of the joint lining) is a prominent
feature in RA. However, bone marrow and liver toxicity limit its use as well as
the danger of development of a lymphoma with prolonged use (Ref. 1).
Cyclophosphamide
is another chemotherapeutic drug that is used in certain cancers. It is somteimes
used for very resistant RA cases where severe synovitis or vasculitis is resistant
to other treatment modalities. However, like with methotrexate the rheumatologist
must be careful to monitor vital organ functions (Ref.1).
Newer approaches to treatment Many
of the anti-aging physicians in Ref. 11 point out that rheumatoid arthritis is
not only an inflammation of the joints, but also a problem where toxic substances
such as heavy metals have accumulated over a long period of time. Intravenous
chelation therapy can be used to remove some of these toxic metals. In addition
Ref. 11 points out that hormone rebalancing may be required (special blood tests
or saliva tests can be ordered by an anti-aging physician who is knowledgeable
in bioidentical hormone replacement). Often there are a number of hormone deficiencies
that get overlooked, such as hypothyroidism and a lack of sex hormones (estrogen,
progesterone, but also DHEA and testosterone). In older persons there often is
a lack of human growth hormone, which can be measured by doing IGF-1 blood tests
(an indicator hormone from the liver that gets stimulated by growth hormone from
the pituitary gland). At the 19th Annual World Congress Anti-Aging and Aesthetic
Medicine in Las Vegas (December 8-10, 2011) Dr. Hertoghe pointed out in several
presentations that hormone production of our hormone glands is diminishing throughout
our lives. In rheumatoid arthritis patients this may occur at a much younger age.
The good news is that replacement of whatever hormone is missing by bio-identical
horomones makes the patients painfree and helps them to remobilize. There
is a consensus recently that RA responds best, if it is treated more aggressively
right in the beginning before the abnormal autoimmune reaction has progressed
too much. O'Dell reports in Ref.3 that RA , which does not respond to methotrexate
alone, will often respond well to a combination of methotrexate with cyclosporine
or combination of methotrexate with leflunomide. Leflunomide
is one of the newer disease modifying agents described in Ref. 4. It prevents
the proliferation of activated lymphocytes by inhibiting a specific enzyme. Leflunomide
is as effective as sulfasalazine or methotrexate. It improves physical function,
prevents erosions on x-rays and improves quality of life (Ref. 4). Other
promising studies have shown that inhibition of the cytokine, tumor
necrosis factor (TNF), through specific monoclonal antibodies (infliximab,
etanercept and others ), will improve the clinical response. They are given by
repeated infusions in intervals for infliximab (brandname: Remicade)
or by subcutaneous injection twice per week with etanercept (brandname: Enbrel).
Occasionally the rheumatologist may combine one of these agents with methotrexate
and it can be more effective this way (Ref. 4 and 5), but at the same time side
effects such as various types of infections also become more common. According
to the authors of Ref. 6 the immunomodifiers that inhibit TNF are a turning point
in the therapeutic management of RA. Food supplements
have been used for a long time for RA, although they are not too useful in active
treatment, they might have an important place in terms of prevention. There is
the theory that a lot of arthritis, if not all of it, has something to do with
the syndrome of insulin resistance (now more aften referred to as "metabolic
syndrome" and the lack of omega-3 fatty acids in our modern diets, which
are rich in sugar and starch (see Ref. 7). This theory is supported by
the observation that high insulin levels dysbalance the ecosanoid metabolism,
which results in more cytokines like TNF that can cause arthritis. By avoiding
intake of refined sugar and too much starch the insulin level can return to normal
levels and by adding omega-3 fatty acids (evening primrose oil, fish oil) and
extracts from New Zealand green lipped mussels the natural anti inflammatory properties
of these food supplements can be utilized to strengthen the immune system. Ref.
8 is useful guide in terms of starting a zone type diet, where these principles
are utilized. However, I am suggesting that patients with RA see a rheumatologist
as well so that these latest immune modifiers mentioned above can also be taken,
if the specialist thinks that this is necessary. The key is to stop the inflammatory
autoimmune process that eats away the cartilage and bone around the joints in
the body (erosive lesions adjacent to the joint on X-rays and periarthritic osteoporosis).
One interesting observation is that calorie restriction can
improve RA on the short term (Ref. 1,p.47). It was speculated that his may mean
that certain foods are allergenic and if they would be avoided, RA would get better.
Others say that the extra calories lead to hyperinsulinism
and the dysbalance of cytokines mentioned above. There may be a combination of
several factors. |